Results 71 to 80 of about 42,923 (283)

Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review

Maternal Health, Neonatology and Perinatology, 2018
Furosemide is a potent loop diuretic commonly and variably used by neonatologists to improve oxygenation and lung compliance in premature infants. There are several safety concerns with use of furosemide in premature infants, specifically the risk of ...
Wesley Jackson, Genevieve Taylor, David Selewski, P. Brian Smith, Sue Tolleson-Rinehart, Matthew M. Laughon   +5 more
doaj   +1 more source

Early in‐hospital treatment of acute heart failure. Part 2 of the international expert opinion series on AHF management

ESC Heart Failure, EarlyView.
This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu, Andrew P. Ambrosy, Gad Cotter, Edimar A. Bocchi, Javed Butler, Ovidiu Chioncel, Beth Davison, Anastase Dzudie, Yonathan Freund, Marat Fudim, Sivadasanpillai Harikrishnan, Ivna G. Cunha, Alexandre Mebazaa, Robert J. Mentz, Òscar Miró, Siti E. Nauli, Mateo Pagnesi, Naoki Sato, Gianluigi Savarese, Karen Sliwa‐Hahnle, Yuhui Zhang, Jingmin Zhou, Jan Biegus   +22 more
wiley   +1 more source

Effect of nitroprusside on furosemide-induced skeletal teratogenicity in rat fetuses

Iranian South Medical Journal, 2016
Background: Furosemide as a loop diuretic can use in treatment of hypertension, renal or heart failures and cirrhosis, when sodium retention is significant.
Mahmood Khaksary Mahabady, Hosean Najafzadeh Varzi, Mozhgan Sabet   +2 more
doaj  

Clinical Usefulness of Furosemide to Prevent Volume Overload Among Children and Young Adults with Transfusion-Dependent Thalassemia: A Randomized, Open-Label, Crossover Study

Journal of Blood Medicine, 2020
Apichat Photia,1 Chanchai Traivaree,1 Chalinee Monsereenusorn,1 Piyarat Simthamnimit,2 Piya Rujkijyanont1 1Division of Hematology-Oncology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand; 2Department of ...
Photia A, Traivaree C, Monsereenusorn C, Simthamnimit P, Rujkijyanont P   +4 more
doaj  

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

ESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra, Daniela Tomasoni, Marianna Adamo, Offer Amir, Stefan D. Anker, Antoni Bayes‐Genis, Michael Boehm, Javed Butler, Ovidiu Chioncel, Gerasimos Filippatos, Finn Gustafsson, Ewa A. Jankowska, Juan Carlos Kaski, Brenda Moura, Mark C. Petrie, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Francois Roubille, Gianluigi Savarese, Petar Seferovic, Peter van der Meer, Maurizio Volterrani, Andrew J. Coats, Vijay K. Chopra, Giuseppe Rosano   +25 more
wiley   +1 more source

Role of NPPB for recovery post ventricular assist device in paediatric dilated cardiomyopathy: Single‐cell multiomics

ESC Heart Failure, EarlyView.
This study investigated factors associated with left ventricular recovery after LVAD implantation in paediatric dilated cardiomyopathy. Patients were classified into recovery and non‐recovery groups. Single‐nucleus sequencing revealed higher NPPB expression and altered apoptosis‐related pathways in the recovery group.
Yosuke Kugo, Takuji Kawamura, Akima Harada, Yuji Tominaga, Kenji Miki, Hidekazu Ishida, Takayoshi Ueno, Shigeru Miyagawa   +7 more
wiley   +1 more source

Development and characterization of furosemide-loaded binary amorphous solid dispersion to enhance solubility and dissolution for pediatric oral administration [PDF]

Pharmacia
Binary co-amorphous systems, as solid dispersions of an active pharmaceutical ingredient with low molecular weight excipients, improve solubility, physical stability, and bioavailability relative to crystalline forms.
Mays Fadhil Mohammed-Kadhum, Ghaidaa S. Hameed   +1 more
doaj   +3 more sources

Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo‐HF study

ESC Heart Failure, EarlyView.
The study evaluated urinary chloride (uCl) and sodium (uNa) trajectories in 70 elderly patients hospitalized with acute heart failure and preserved ejection fraction (HFpEF). Urine samples were collected at baseline, 24, 48 and 72 h. A multiparametric approach assessed decongestion using the clinical congestion score (CCS), portal vein (PV) pulsatility
Jorge Campos, Pau Llàcer, François Croset, Marina García, Carlos Pérez, Alberto Pérez, Marina Vergara, Paul Cevallos, Martín Fabregate, Cristina Fernández, Raúl Ruiz, Daniel Useros, Miriam Menacho, Miriam Domínguez, Esteban Pérez, Julio Núñez, Luis Manzano   +16 more
wiley   +1 more source

The utility of urine biomarkers in diuretic resistance prediction in heart failure hospitalization

ESC Heart Failure, EarlyView.
High urine pi‐GST concentration might be a marker for the development of loop diuretic resistance in patients with congestive heart failure hospitalization. Abstract Aims Loop diuretic resistance (LDR) in patients with heart failure hospitalization (HHF) is associated with worse clinical outcomes.
Tomasz Imiela, Piotr Poplawski, Beata Zaborska, Ewa Pilichowska‐Paszkiet, Anna M. Imiela, Tomasz Bednarczyk, Katarzyna Piszcz, Andrzej Budaj   +7 more
wiley   +1 more source

Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review

European Journal of Heart Failure, EarlyView.
This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.
Yuxiang Luo, Wenbin Xiao, Yusuf Z. Sener, Wouter C. Meijers, Robert M.A. van der Boon, Elfatih A. Hasabo, Osama Soliman, Rudolf A. de Boer, Kadir Caliskan   +8 more
wiley   +1 more source